← Back to Company DatabaseVisit Website
Exact Sciences
Cancer screening and diagnostic tests for early detection.
PublicMadison, WIFounded 1995
About
Exact Sciences is a molecular diagnostics company specializing in cancer screening and diagnostics. Its Cologuard test is a widely used non-invasive colorectal cancer screening tool, and its Oncotype DX test guides breast cancer treatment decisions. The company also acquired Thrive Earlier Detection to expand into multi-cancer early detection.
Total Funding
UndisclosedKey Product
Cologuard colorectal cancer screening testGeography
North AmericaKey Investors
Third PointBlackRockVanguard
Focus Areas
Early Detection / ScreeningDiagnostics
Technology
Genomics / SequencingLiquid BiopsyAI / Machine Learning
Cancer Types
ColorectalBreastPan-cancer
Last updated: Feb 4, 2026